{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:43:08Z","timestamp":1792809788912,"version":"4.5.0"},"reference-count":115,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Ebola Virus Disease (EVD) is one of the most lethal transmissible infections, characterized by a high fatality rate, and caused by a member of the Filoviridae family. The recent large outbreak of EVD in Western Africa (2013\u20132016) highlighted the worldwide threat represented by the disease and its impact on global public health and the economy. The development of highly needed anti-Ebola virus antivirals has been so far hampered by the shortage of tools to study their life cycle in vitro, allowing to screen for potential active compounds outside a biosafety level-4 (BSL-4) containment. Importantly, the development of surrogate models to study Ebola virus entry in a BSL-2 setting, such as viral pseudotypes and Ebola virus-like particles, tremendously boosted both our knowledge of the viral life cycle and the identification of promising antiviral compounds interfering with viral entry. In this context, the combination of such surrogate systems with large-scale small molecule compounds and haploid genetic screenings, as well as rational drug design and drug repurposing approaches will prove priceless in our quest for the development of a treatment for EVD.<\/jats:p>","DOI":"10.3390\/v11030274","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T12:12:25Z","timestamp":1552997545000},"page":"274","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Ebola Virus Entry: From Molecular Characterization to Drug Discovery"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5136-7406","authenticated-orcid":false,"given":"Cristiano","family":"Salata","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, University of Padova, IT-35121 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Calistri","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Padova, IT-35121 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-3616","authenticated-orcid":false,"given":"Gualtiero","family":"Alvisi","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Padova, IT-35121 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Celestino","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Padova, IT-35121 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Parolin","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Padova, IT-35121 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Pal\u00f9","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Padova, IT-35121 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41564-018-0227-2","article-title":"The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses","volume":"3","author":"Goldstein","year":"2018","journal-title":"Nat. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41564-018-0328-y","article-title":"Characterization of a filovirus (M\u011bngl\u00e0 virus) from Rousettus bats in China","volume":"4","author":"Yang","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1093\/infdis\/jiy280","article-title":"Ebola Virus Transmission Caused by Persistently Infected Survivors of the 2014\u20132016 Outbreak in West Africa","volume":"218","author":"Subissi","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/femsre\/fuw010","article-title":"Neglected filoviruses","volume":"40","author":"Burk","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The Pathogenesis of Ebola Virus Disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Saeed, M.F., Kolokoltsov, A.A., Albrecht, T., and Davey, R.A. (2010). Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001110"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Nanbo, A., Imai, M., Watanabe, S., Noda, T., Takahashi, K., Neumann, G., Halfmann, P., and Kawaoka, Y. (2010). Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001121"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2011.08.009","article-title":"The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway","volume":"419","author":"Mulherkar","year":"2011","journal-title":"Virology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.2000.0601","article-title":"Downregulation of \u03b21 Integrins by Ebola Virus Glycoprotein: Implication for Virus Entry","volume":"278","author":"Takada","year":"2000","journal-title":"Virology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1128\/JVI.76.13.6841-6844.2002","article-title":"C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans","volume":"76","author":"Alvarez","year":"2002","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2011.02.110","article-title":"Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin","volume":"407","author":"Usami","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1073\/pnas.1019030108","article-title":"T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus","volume":"108","author":"Kondratowicz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Brudner, M., Karpel, M., Lear, C., Chen, L., Yantosca, L.M., Scully, C., Sarraju, A., Sokolovska, A., Zariffard, M.R., and Eisen, D.P. (2013). Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060838"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/viro.2002.1730","article-title":"DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells","volume":"305","author":"Simmons","year":"2003","journal-title":"Virology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/JVI.78.6.2943-2947.2004","article-title":"Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry","volume":"78","author":"Takada","year":"2004","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1086\/520594","article-title":"The mechanism of Axl-mediated Ebola virus infection","volume":"196","author":"Shimojima","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1128\/JVI.01956-08","article-title":"The primed ebolavirus glycoprotein (19-kilodalton GP1,2): Sequence and residues critical for host cell binding","volume":"83","author":"Dube","year":"2009","journal-title":"J. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1073\/pnas.0807578106","article-title":"\u03b15\u03b21-Integrin controls ebolavirus entry by regulating endosomal cathepsins","volume":"106","author":"Schornberg","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2011.04.002","article-title":"Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein","volume":"415","author":"Brindley","year":"2011","journal-title":"Virology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/JVI.01278-09","article-title":"The Tyro3 Receptor Kinase Axl Enhances Macropinocytosis of Zaire Ebolavirus","volume":"85","author":"Hunt","year":"2011","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1128\/JVI.00136-12","article-title":"Ebolavirus Requires Acid Sphingomyelinase Activity and Plasma Membrane Sphingomyelin for Infection","volume":"86","author":"Miller","year":"2012","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JVI.02151-09","article-title":"Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: Implications for viral entry and immunogenicity","volume":"84","author":"Hood","year":"2010","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JVI.05708-11","article-title":"Cathepsin Cleavage Potentiates the Ebola Virus Glycoprotein To Undergo a Subsequent Fusion-Relevant Conformational Change","volume":"86","author":"Brecher","year":"2012","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e02154-15","DOI":"10.1128\/mBio.02154-15","article-title":"Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies","volume":"7","author":"Bornholdt","year":"2016","journal-title":"mBio"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann\u2013Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann\u2013Pick C1 is essential for Ebola virus infection","volume":"477","author":"Misasi","year":"2011","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/emboj.2012.53","article-title":"Ebola virus entry requires the host-programmed recognition of an intracellular receptor","volume":"31","author":"Miller","year":"2012","journal-title":"EMBO J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.1258758","article-title":"Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/JVI.01828-15","article-title":"Ebolavirus Glycoprotein Directs Fusion through NPC1+ Endolysosomes","volume":"90","author":"Simmons","year":"2016","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrmicro2764","article-title":"A new player in the puzzle of filovirus entry","volume":"10","author":"White","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/BF01314961","article-title":"The glycoprotein G of rhabdoviruses","volume":"140","author":"Coll","year":"1995","journal-title":"Arch. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S1075","DOI":"10.1093\/infdis\/jir349","article-title":"Recombinant Vesicular Stomatitis Virus\u2013Based Vaccines Against Ebola and Marburg Virus Infections","volume":"204","author":"Geisbert","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","article-title":"Generation of VSV pseudotypes using recombinant \u0394G-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines","volume":"169","author":"Whitt","year":"2010","journal-title":"J. Virol. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-4939-3387-7_16","article-title":"Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses","volume":"Volume 1403","author":"Clifton","year":"2016","journal-title":"Methods in Molecular Biology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.apsb.2017.08.003","article-title":"Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors","volume":"8","author":"Chen","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-4690-1-9","article-title":"Early steps of retrovirus replicative cycle","volume":"1","author":"Nisole","year":"2004","journal-title":"Retrovirology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"a006924","DOI":"10.1101\/cshperspect.a006924","article-title":"HIV-1 Assembly, Budding, and Maturation","volume":"2","author":"Sundquist","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12967-016-1047-x","article-title":"Retroviral vectors and transposons for stable gene therapy: Advances, current challenges and perspectives","volume":"14","author":"Vargas","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/hgtb.2017.084","article-title":"Pseudotyped Lentiviral Vectors: One Vector, Many Guises","volume":"28","author":"Joglekar","year":"2017","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/jmbi.2000.3822","article-title":"Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus","volume":"300","author":"Ruigrok","year":"2000","journal-title":"J. Mol. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0042-6822(03)00260-5","article-title":"Oligomerization and polymerization of the filovirus matrix protein VP40","volume":"312","author":"Timmins","year":"2003","journal-title":"Virology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cell.2013.07.015","article-title":"Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle","volume":"154","author":"Bornholdt","year":"2013","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"13871","DOI":"10.1073\/pnas.250277297","article-title":"A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding","volume":"97","author":"Harty","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/JVI.75.11.5205-5214.2001","article-title":"Ebola virus VP40-induced particle formation and association with the lipid bilayer","volume":"75","author":"Jasenosky","year":"2001","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2001.0860","article-title":"Vesicular Release of Ebola Virus Matrix Protein VP40","volume":"283","author":"Timmins","year":"2001","journal-title":"Virology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1128\/JVI.00051-06","article-title":"Infection of naive target cells with virus-like particles: Implications for the function of ebola virus VP24","volume":"80","author":"Hoenen","year":"2006","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"S884","DOI":"10.1093\/infdis\/jir359","article-title":"Conserved proline-rich region of Ebola virus matrix protein VP40 is essential for plasma membrane targeting and virus-like particle release","volume":"204","author":"Reynard","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1462-5822.2009.01385.x","article-title":"Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition","volume":"12","author":"Martinez","year":"2010","journal-title":"Cell. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jviromet.2009.10.020","article-title":"An enzymatic virus-like particle assay for sensitive detection of virus entry","volume":"163","author":"Tscherne","year":"2010","journal-title":"J. Virol. Methods"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.06.003","article-title":"Minigenomes, transcription and replication competent virus-like particles and beyond: Reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses","volume":"91","author":"Hoenen","year":"2011","journal-title":"Antivir. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1586\/14787210.2014.948848","article-title":"Reverse genetics systems as tools for the development of novel therapies against filoviruses","volume":"12","author":"Hoenen","year":"2014","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1128\/JVI.01272-14","article-title":"A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity","volume":"88","author":"Watt","year":"2014","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.09.001","article-title":"Filovirus proteins for antiviral drug discovery: A structure\/function analysis of surface glycoproteins and virus entry","volume":"135","author":"Martin","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40506-017-0130-z","article-title":"Discovering Drugs for the Treatment of Ebola Virus","volume":"9","author":"Bixler","year":"2017","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.curtheres.2017.01.007","article-title":"Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review","volume":"84","author":"Sweiti","year":"2017","journal-title":"Curr. Ther. Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Salata, C., Calistri, A., Parolin, C., Baritussio, A., and Pal\u00f9, G. (2017). Antiviral activity of cationic amphiphilic drugs. Expert Rev. Anti-Infect. Ther., 15.","DOI":"10.1080\/14787210.2017.1305888"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/jac\/dku091","article-title":"The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry","volume":"69","author":"Gehring","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Salata, C., Baritussio, A., Munegato, D., Calistri, A., Ha, H.R., Bigler, L., Fabris, F., Parolin, C., Pal\u00f9, G., and Mirazimi, A. (2015). Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process. Pathog. Dis., 73.","DOI":"10.1093\/femspd\/ftv032"},{"key":"ref_64","first-page":"162","article-title":"Amiodarone affects Ebola virus binding and entry into target cells","volume":"41","author":"Salata","year":"2018","journal-title":"New Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/acsinfecdis.5b00030","article-title":"Evaluation of Ebola Virus Inhibitors for Drug Repurposing","volume":"1","author":"Madrid","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(14)62384-9","article-title":"Severe Ebola virus disease with vascular leakage and multiorgan failure: Treatment of a patient in intensive care","volume":"385","author":"Wolf","year":"2015","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1172\/JCI83111","article-title":"Blood kinetics of Ebola virus in survivors and nonsurvivors","volume":"125","author":"Lanini","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S592","DOI":"10.1093\/infdis\/jiy345","article-title":"In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus","volume":"218","author":"Dyall","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"290ra89","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A screen of approved drugs and molecular probes identifies therapeutics with anti\u2013Ebola virus activity","volume":"7","author":"Johansen","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acs.jmedchem.7b01249","article-title":"Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection","volume":"61","author":"Ren","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"S588","DOI":"10.1093\/infdis\/jiy332","article-title":"The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus Disease","volume":"218","author":"DeWald","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2016.05.017","article-title":"Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library","volume":"132","author":"Beck","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cbf.3182","article-title":"Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity","volume":"34","author":"Akpovwa","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1473-3099(11)70092-5","article-title":"Use of chloroquine in viral diseases","volume":"11","author":"Savarino","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Madrid, P.B., Chopra, S., Manger, I.D., Gilfillan, L., Keepers, T.R., Shurtleff, A.C., Green, C.E., Iyer, L.V., Dilks, H.H., and Davey, R.A. (2013). A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060579"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3201\/eid2106.150176","article-title":"Lack of Protection Against Ebola Virus from Chloroquine in Mice and Hamsters","volume":"21","author":"Falzarano","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1099\/jgv.0.000309","article-title":"Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model","volume":"96","author":"Dowall","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504605","article-title":"Effect of Artesunate\u2013Amodiaquine on Mortality Related to Ebola Virus Disease","volume":"374","author":"Gignoux","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.antiviral.2018.08.013","article-title":"High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system","volume":"158","author":"Lee","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12985-016-0607-2","article-title":"Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry","volume":"13","author":"Beck","year":"2016","journal-title":"Virol. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-018-0034-1","article-title":"Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: Inhibiting viral replication and decreasing viral entry","volume":"4","author":"Yang","year":"2018","journal-title":"Cell Discov."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1038\/emi.2014.88","article-title":"Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs","volume":"3","author":"Kouznetsova","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.1074\/jbc.M116.716100","article-title":"Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome\/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)","volume":"291","author":"Zhou","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2015.11.003","article-title":"Teicoplanin inhibits Ebola pseudovirus infection in cell culture","volume":"125","author":"Wang","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Shoemaker, C.J., Schornberg, K.L., Delos, S.E., Scully, C., Pajouhesh, H., Olinger, G.G., Johansen, L.M., and White, J.M. (2013). Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection. PLoS ONE, 8.","DOI":"10.1371\/annotation\/76780c06-ac81-48a3-8cce-509da6858fe5"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.virol.2010.02.015","article-title":"Ebola virus uses clathrin-mediated endocytosis as an entry pathway","volume":"401","author":"Bhattacharyya","year":"2010","journal-title":"Virology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/tra.12272","article-title":"Phenothiazine-Derived Antipsychotic Drugs Inhibit Dynamin and Clathrin-Mediated Endocytosis","volume":"16","author":"Daniel","year":"2015","journal-title":"Traffic"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1128\/JVI.01337-15","article-title":"Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists","volume":"89","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2018.07.003","article-title":"Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics","volume":"157","author":"Schafer","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.antiviral.2017.06.015","article-title":"Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor","volume":"145","author":"Cheng","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"190ra79","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection","volume":"5","author":"Johansen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature18615","article-title":"Toremifene interacts with and destabilizes the Ebola virus glycoprotein","volume":"535","author":"Zhao","year":"2016","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"41226","DOI":"10.1038\/srep41226","article-title":"Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Nelson, E., Barnes, A., Wiehle, R., Fontenot, G., Hoenen, T., and White, J. (2016). Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications. Viruses, 8.","DOI":"10.3390\/v8080206"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"123ra24","DOI":"10.1126\/scitranslmed.3003500","article-title":"Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase","volume":"4","author":"Garcia","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Nelson, E.A., Dyall, J., Hoenen, T., Barnes, A.B., Zhou, H., Liang, J.Y., Michelotti, J., Dewey, W.H., DeWald, L.E., and Bennett, R.S. (2017). The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005540"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"S672","DOI":"10.1093\/infdis\/jiy304","article-title":"Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures","volume":"218","author":"Dyall","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.antiviral.2014.04.014","article-title":"Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells","volume":"107","author":"Johnson","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/JVI.02705-14","article-title":"AP-2-Associated Protein Kinase 1 and Cyclin G-Associated Kinase Regulate Hepatitis C Virus Entry and Are Potential Drug Targets","volume":"89","author":"Neveu","year":"2015","journal-title":"J. Virol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/acs.jmedchem.8b00613","article-title":"Optimization of Isothiazolo[4,3- b ]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity","volume":"61","author":"Pu","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Moeschler, S., Locher, S., and Zimmer, G. (2018). 1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features. Viruses, 10.","DOI":"10.3390\/v10060306"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1128\/JVI.01456-10","article-title":"Identification of a Small-Molecule Entry Inhibitor for Filoviruses","volume":"85","author":"Basu","year":"2011","journal-title":"J. Virol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1093\/infdis\/jiv223","article-title":"Novel Small Molecule Entry Inhibitors of Ebola Virus","volume":"212","author":"Basu","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/AAC.00543-16","article-title":"Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors","volume":"60","author":"Anantpadma","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejmech.2018.02.061","article-title":"Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage","volume":"149","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Cui, Q., Du, R., Anantpadma, M., Schafer, A., Hou, L., Tian, J., Davey, R., Cheng, H., and Rong, L. (2018). Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor. Viruses, 10.","DOI":"10.3390\/v10040152"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2017.11.016","article-title":"Retro-2 and its dihydroquinazolinone derivatives inhibit filovirus infection","volume":"149","author":"Shtanko","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cmdc.201800587","article-title":"Phenotypic Prioritization of Diphyllin Derivatives That Block Filoviral Cell Entry by Vacuolar (H+)-ATPase Inhibition","volume":"13","author":"Lindstrom","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/acsinfecdis.5b00130","article-title":"Cysteine Cathepsin Inhibitors as Anti-Ebola Agents","volume":"2","author":"Schulze","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Cui, Q., Cheng, H., Xiong, R., Zhang, G., Du, R., Anantpadma, M., Davey, R., and Rong, L. (2018). Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus. Viruses, 10.","DOI":"10.3390\/v10120678"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"15854","DOI":"10.1074\/jbc.M110.207084","article-title":"Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes","volume":"286","author":"Miller","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.04.020","article-title":"Novel cyclo-peptides inhibit Ebola pseudotyped virus entry by targeting primed GP protein","volume":"155","author":"Li","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2016.11.017","article-title":"Synergistic drug combination effectively blocks Ebola virus infection","volume":"137","author":"Sun","year":"2017","journal-title":"Antivir. Res."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/3\/274\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:38:53Z","timestamp":1760186333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/3\/274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":115,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["v11030274"],"URL":"https:\/\/doi.org\/10.3390\/v11030274","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201902.0209.v1","asserted-by":"object"}]},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]}}}